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Cardiovascular disease (CVD) remains the leading cause of
death globally. The identiﬁcation of traditional risk factors
such as age, hypercholesterolemia, hypertension, diabetes
mellitus, and smoking has improved primary prevention of
CVD.However, the overallmortality related to cardiovascular
disease is still rising. Further scientiﬁc advances have led to the
discovery of a broad range of novel biomarkers associated
with cardiovascular risks, including B-type natriuretic peptide
(BNP), N-terminal prohormone BNP (NT-proBNP), tro-
ponin, C-reactive protein (CRP), myeloperoxidase (MPO),
lipoprotein-associated phospholipase A2, ﬁbrinogen, TMAO,
and cystatin C. Although these biomarkers have a prognostic
value independent of the previous traditional risk factors, only
a few have become important diagnostic tools in clinical
practice. BNP and NT-proBNP have proven clinical utility
in the diagnosis of heart failure and/or heart failure exacerba-
tion. Troponin has been used as a cardiac biomarker for
diagnosis and risk stratiﬁcation of patients with suspected
acute coronary syndrome (ACS). The blood levels of high
sensitivity CRP (hs CRP) have been used to assess the risk of
CVD, heart attack, and stroke. Circulating levels ofMPOhave
been used to predict risks of coronary heart disease. However,
so far, none of these biomarkers has signiﬁcantly improved
distinction between health and disease status. There remain
tremendous challenges to scientists and clinicians in the
discovery of novel biomarkers that may improve risk
prediction of CVD, monitor disease progression, and poten-
tially be used as therapeutic targets before clinical signs and
symptoms appear.
This special issue contains nine papers, covering several
aspects of biomarkers associated with cardiovascular disease.
In six of the nine papers, the authors conduct small-scale
retrospective cross-sectional or prospective clinical human
studies to evaluate the clinical relevance of diﬀerent bio-
markers related to diverse disease conditions such as type 2
diabetes, acute ischemic stroke, heart failure, and aortic valve
calciﬁcation. The biomarkers reported in this issue are
miRNAs, cytokine IL-37, urinary NGAL, insulin resistance,
metalloproteinase-8, metalloproteinase-1, parathyroid hor-
mone, and lactate. Although respective authors have
provided some evidence to show the promising prognostic
value of these biomarkers, it is still unknown whether these
markers will have a diagnostic impact or clinical implica-
tions. Also included in this special issue are three interesting
review papers that discussed the eﬀect of multiple vitamins,
platelet miRNA expression proﬁle, and ischemia-modiﬁed
albumin on disease status.
In the paper “Plasma IL-37 Elevated in Patients with
Chronic Heart Failure and Predicted Major Adverse
CardiacEvents:A1-YearFollow-UpStudy,”X.Shouet al. pro-
vided evidence that circulating level of anti-inﬂammatory
cytokine IL-37 is associated with increased risks for chronic
heart failure.
In the paper “Parathyroid Hormone Levels in the Predic-
tion of Ischemic Stroke Risk,” G. Çelik et al. performed a
prospective study that examined parathyroid hormone
(PTH) and/or 1,25-dihydroxyvitamin D (1, 25(OH)2 D)
levels in 100 subjects who had acute ischemic stroke and
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100 healthy control subjects. Their results suggested that
PTH and 1,25(OH)2 D levels together may promote the
determination of stroke risks.
In the paper “Handheld Capillary Blood Lactate Analyzer
as an Accessible and Cost-Eﬀective Prognostic Tool for the
Assessment of Death and Heart Failure Occurrence during
Long-Term Follow-Up,” G. M. Kubiak et al. measured capil-
lary blood lactate levels with a handheld analyzer in a total of
145 consecutive patients admitted to hospitals after acute
myocardial infarction. The authors demonstrated that lactate
levels may serve as a potential prognostic marker of late onset
heart failure and death after acute myocardial infarction.
In the paper “Is Urinary NGAL Determination Useful for
Monitoring Kidney Function and Assessment of Cardiovas-
cular Disease? A 12-Month Observation of Patients with type
2 Diabetes,” A Żyłka et al. assessed kidney function by
monitoring the levels of urinary neutrophil gelatinase-
associated lipocalin (uNGAL) in patients with type 2 diabetes
mellitus (T2DM) after initiation of nephron-protective
treatment in a one-year follow-up study. The authors found
that better glycemic control in T2DM patients results in a
signiﬁcant decrease in uNGAL which is correlated with a
signiﬁcant improvement in renal function and the lowering
of cardiovascular risk.
In the paper “Insulin Resistance in Adipose Tissue but
Not in Liver Is Associated with Aortic Valve Calciﬁca-
tion,” the authors present a cross-sectional clinical study
with 1201 study population participating in the Genetics
of Atherosclerotic Disease study. They discovered that
adipose tissue insulin resistance is positively associated
with the prevalent risks for aortic valve calciﬁcation (OR:
2.40: 95% CI: 1.30–4.43). They also found no association
between adipose tissue insulin resistance and coronary
artery calciﬁcation.
The paper by J. Mieczkowska et al. showed that circulat-
ing levels of inﬂammatory biomarker metalloproteinase-8
(MMP-8) and tissue inhibitor of metalloproteinase-1
(TIMP-1) are negatively correlated with a heart rate in
postmenopausal women during exercise treadmill testing.
The review paper by I. Mozos et al. discussed the latest
studies related to the eﬀect of multiple vitamins on arterial
stiﬀness. They suggested that vitamins A, B12, D, K, C, and
E may be potential biomarkers for arterial stiﬀness.
The review by M. Bijak et al. touches upon a recently
discovered diagnostic value of proﬁling miRNAs in platelets
of diseased versus heathy controls. This review summarized
interesting and thought-provoking studies implicating the
role of platelet miRNAs in various diseases. More speciﬁcally,
the described studies highlighted the role of (1) miRNA-340/
miRNA-624 in premature coronary artery disease patients,
(2) miRNA150 in heart failure with atrial ﬁbrillation, (3)
miRNA-154/miRNA-329/miRNA-376 in sickle cell disease,
and (4) miRNA-144/miRNA-223/miRNA-146a in type 2
diabetes patients with ischemic stroke.
In their review, I. Oran et al. proposed a revised concept of
fatty acid-occupied albumin, rather than ischemia-modiﬁed
albumin, as a biomarker of acute coronary syndrome.
This special issue is aimed to broaden our knowledge on
biomarkers of cardiovascular disease.
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